Shin-Ichiro Hamano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shin-Ichiro Hamano has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Atsuko Oba
Division of Neurology, Saitama Children's Medical Center, Saitama, Japan
2 shared publications- Ryuki Matsuura
Division of Neurology Saitama Children's Medical Center Saitama Japan
2 shared publications - Atsuro Daida
Division of Pediatric Neurology, Department of Pediatrics, University of California, Los Angeles
1 shared publication Erika Hiwatari
Department for Child Health and Human Development, Saitama Children's Medical Center, Saitama, Japan
1 shared publicationHiroyuki Ida
1 shared publication- Jun Kubota
Division of Neurology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, Japan; Department of Pediatrics, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan
1 shared publication
Latest Publications
- 1 May 2019
- Published by Elsevier in Brain and Development
- Vol. 41 (5) , 413-419
Efficacy and safety of pyridoxal in West syndrome: A retrospective study
- 1 May 2019
- Published by Elsevier in Brain and Development
- Vol. 41 (5) , 413-419
Efficacy and safety of pyridoxal in West syndrome: A retrospective study
- 1 January 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 396, 150-158
Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus
- 1 January 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 396, 150-158
Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus
- 1 September 2018
- Published by Elsevier in Brain and Development
- Vol. 40 (8) , 685-692
Treatment of infantile spasms by pediatric neurologists in Japan
- 1 September 2018
- Published by Elsevier in Brain and Development
- Vol. 40 (8) , 685-692
Treatment of infantile spasms by pediatric neurologists in Japan
- 1 January 2014
- Published by The Japan Epilepsy Society in Journal of the Japan Epilepsy Society
- Vol. 31 (3) , 491-497
Efficacy of Fosphenytoin for Status Epilepticus and Cluster Seizures in Children
小児てんかん重積状態および発作頻発に対するfosphenytoin(fos-PHT)の有用性と薬物動態について、2歳未満と2歳以上の2群にわけて検討した。有効率は、2歳未満と2歳以上でともに約70%であった。副作用は2歳以上の1例で認められ、一過性血圧低下を呈したが自然回復した。初回投与(22.5mg/kg)後のphenytoin(PHT)血中濃度の変化は、2歳未満と2歳以上で有意差はなく、10~15時間で有効血中濃度を下回った。維持投与(7.5mg/kg/day)では、投与期間が長くなるとトラフ値PHT血中濃度が減少し、有効血中濃度は維持できなかった。本剤は、2歳未満を含めた小児てんかん重積状態および発作頻発に対して有効かつ安全に使用できると考えられた。PHT有効血中濃度を維持するために、fos-PHTの初回投与量と維持投与量は、海外での推奨投与量と同程度まで使用したほうがよいと思われた。
- 1 January 2014
- Published by The Japan Epilepsy Society in Journal of the Japan Epilepsy Society
- Vol. 31 (3) , 491-497
Efficacy of Fosphenytoin for Status Epilepticus and Cluster Seizures in Children
小児てんかん重積状態および発作頻発に対するfosphenytoin(fos-PHT)の有用性と薬物動態について、2歳未満と2歳以上の2群にわけて検討した。有効率は、2歳未満と2歳以上でともに約70%であった。副作用は2歳以上の1例で認められ、一過性血圧低下を呈したが自然回復した。初回投与(22.5mg/kg)後のphenytoin(PHT)血中濃度の変化は、2歳未満と2歳以上で有意差はなく、10~15時間で有効血中濃度を下回った。維持投与(7.5mg/kg/day)では、投与期間が長くなるとトラフ値PHT血中濃度が減少し、有効血中濃度は維持できなかった。本剤は、2歳未満を含めた小児てんかん重積状態および発作頻発に対して有効かつ安全に使用できると考えられた。PHT有効血中濃度を維持するために、fos-PHTの初回投与量と維持投与量は、海外での推奨投与量と同程度まで使用したほうがよいと思われた。
- 1 November 2010
- Vol. 42 (6) , 432-6
[Clinical re-evaluation of pediatric inflammatory disorders of the central nervous system:a study based on the new classification criteria proposed by the International Pediatric MS Study Group].
A retrospective analysis of the clinical and MRI features in 20 Japanese children diagnosed with central nervous system inflammatory demyelinating disorders was performed. Using the new criteria proposed by International Pediatric MS Study Group, half of children were reclassified into clinical isolated demyelinating syndrome (CIS). Presence of seizures and a pattern of diffuse bilateral lesions on brain MRIs are more frequent in children with ADEM than in CIS. However we suggest these features and encephalopathy may be associated with the age of patients. Furthermore, though persistence of abnormal MRI lesions is significantly more likely in the group of CIS, none of these patients had a subsequent recurrence or developed MS during the follow-up period. The prediction of patient prognosis seems to be difficult even based on the new criteria, and the nationwide multicenter analysis may be necessary in Japan for acquiring the definite conclusion.
- 1 November 2010
- Vol. 42 (6) , 432-6
[Clinical re-evaluation of pediatric inflammatory disorders of the central nervous system:a study based on the new classification criteria proposed by the International Pediatric MS Study Group].
A retrospective analysis of the clinical and MRI features in 20 Japanese children diagnosed with central nervous system inflammatory demyelinating disorders was performed. Using the new criteria proposed by International Pediatric MS Study Group, half of children were reclassified into clinical isolated demyelinating syndrome (CIS). Presence of seizures and a pattern of diffuse bilateral lesions on brain MRIs are more frequent in children with ADEM than in CIS. However we suggest these features and encephalopathy may be associated with the age of patients. Furthermore, though persistence of abnormal MRI lesions is significantly more likely in the group of CIS, none of these patients had a subsequent recurrence or developed MS during the follow-up period. The prediction of patient prognosis seems to be difficult even based on the new criteria, and the nationwide multicenter analysis may be necessary in Japan for acquiring the definite conclusion.
- 1 September 2008
- Vol. 40 (5) , 375-80
[Posterior leukoencephalopathy syndrome in children--clinical and neuroradiological findings].
We reported the clinical and neuroradiological findings of 8 patients (4 males; 4 females; age range; 3 - 14 years) with posterior leukoencephalopathy syndrome (PLES). Previous case reports suggested that one of the major factors leading to PLES was severe hypertension. We divided the patients into two groups with or without severe hypertension, and each group was divided furthermore into two corresponding to the reversibility of brain lesions. The four cases of PLES with severe hypertension were all due to renal hypertension, and half of them resulted in irreversible outcomes, which were considered to be associated with inappropriate treatment. On the other hand, the four cases of PLES without severe hypertension showed reversible change, suggesting intravascular endothelial dysfuncton in respect of their causing factors. We consider that PLES could be caused without sever hypertension, particularly in children. Those with severe hypertension must be treated immediately to prevent irreversible brain damage.
- 1 September 2008
- Vol. 40 (5) , 375-80
[Posterior leukoencephalopathy syndrome in children--clinical and neuroradiological findings].
We reported the clinical and neuroradiological findings of 8 patients (4 males; 4 females; age range; 3 - 14 years) with posterior leukoencephalopathy syndrome (PLES). Previous case reports suggested that one of the major factors leading to PLES was severe hypertension. We divided the patients into two groups with or without severe hypertension, and each group was divided furthermore into two corresponding to the reversibility of brain lesions. The four cases of PLES with severe hypertension were all due to renal hypertension, and half of them resulted in irreversible outcomes, which were considered to be associated with inappropriate treatment. On the other hand, the four cases of PLES without severe hypertension showed reversible change, suggesting intravascular endothelial dysfuncton in respect of their causing factors. We consider that PLES could be caused without sever hypertension, particularly in children. Those with severe hypertension must be treated immediately to prevent irreversible brain damage.